Live from the NIH registry
Studies recruiting near Concord right now
Top 25 of 651 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Atrium Health Levine Children's Hospital — Charlotte, North Carolina (16.3 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Carolinas Medical Center/Levine Children's Hospital (Adults and Pediatrics) — Charlotte, North Carolina (16.3 mi)
· Sponsor: Pierre Fabre Medicament
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Atrium Health — Charlotte, North Carolina (16.3 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Carolina BioOncology Institute — Huntersville, North Carolina (11.7 mi)
· Sponsor: Revolution Medicines, Inc.
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
Phase 4
Interventional 60 participants sought
Research Site — Charlotte, North Carolina (16.3 mi)
· Sponsor: AstraZeneca
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (16.3 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Monroe Biomedical Research — Monroe, North Carolina (28.6 mi)
· Sponsor: Genentech, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Atrium Health — Charlotte, North Carolina (16.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (16.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Research Carolina Elite — Denver, North Carolina (24.1 mi)
· Sponsor: Eisai Inc.
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Charlotte, North Carolina (16.3 mi)
· Sponsor: Kinaset Therapeutics Inc
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
HIV Infections
Phase 3
Interventional 850 participants sought
Rosedale Health and Wellness — Huntersville, North Carolina (11.7 mi)
· Sponsor: Gilead Sciences
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Charlotte, North Carolina (16.3 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Pediatric Cancer
Phase 2
Interventional 64 participants sought
Levine Cancer Institute — Charlotte, North Carolina (16.3 mi)
· Sponsor: Wake Forest University Health Sciences
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Atrium Health - Carolinas Medical Center — Charlotte, North Carolina (16.3 mi)
· Sponsor: Abbott Medical Devices
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Prostatic Neoplasms
Phase 1
Interventional 355 participants sought
Atrium Health Levine Cancer Institute — Charlotte, North Carolina (16.3 mi)
· Sponsor: Janssen Research & Development, LLC
Caring Connections Youth Suicide Detection and Intervention Study
Suicide, Suicide Prevention
N/A
Interventional 180 participants sought
The University of North Carolina at Charlotte — Charlotte, North Carolina (16.3 mi)
· Sponsor: University of North Carolina, Chapel Hill
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Atrium Health Cabarrus/LCI-Concord — Concord, North Carolina (3.3 mi)
· Sponsor: NRG Oncology
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Huntersville, North Carolina (11.7 mi)
· Sponsor: Alkermes, Inc.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Novant Health Cancer Institute — Charlotte, North Carolina (16.3 mi)
· Sponsor: Hoffmann-La Roche
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
Phase 2
Interventional 230 participants sought
Research Site — Salisbury, North Carolina (21.3 mi)
· Sponsor: AstraZeneca
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 499 participants sought
Clinical Trial Site — Huntersville, North Carolina (11.7 mi)
· Sponsor: Arvinas Inc.
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Solid Tumor, Adult, Healthy Donors
N/A
Observational 1,500 participants sought
Carolina BioOncology Institute — Huntersville, North Carolina (11.7 mi)
· Sponsor: BioCytics, Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Atrium Health Carolinas Medical Center — Charlotte, North Carolina (16.3 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Novant Health Presbyterian Medical Center /ID# 230201 — Charlotte, North Carolina (16.3 mi)
· Sponsor: AbbVie